LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Latest News & Commentary

Top 25 of ’25: Discovery & Development eBook

Top 25 of ’25: Discovery & Development eBook

Curated insight from the leaders shaping Drug Discovery and Formulation Delivery
News
Executive Interview with Joshua Baughman, Bristol Myers Squibb
Thought Leadership

Executive Interview with Joshua Baughman, Bristol Myers Squibb

Joshua Baughman Scientific Director, Bristol Myers Squibb
Thought Leadership
Drug Discovery
Executive Interview with Sam Moorcroft, BioOrbit
Thought Leadership

Executive Interview with Sam Moorcroft, BioOrbit

Sam Moorcroft Director of Partnerships, BioOrbit
Thought Leadership
Drug Discovery
Revolutionary Eye Implant Gives Blind Patients A New lease of Life

Revolutionary Eye Implant Gives Blind Patients A New lease of Life

Lucia Simmen Senior Digital Content Editor, Oxford Global
News
Therapeutics
Market Insight

How Polyanion Alginate Oligosaccharides Boost LNP Delivery

Philip Rye Chief Scientific Officer, AlgiPharma
Market Insight
Drug Development
D&D LSX - Connect with Peers

Latest Technology Spotlights
The Power of Nanoporous Silicon Dioxide for the Delivery of Large and Small Molecules

The Power of Nanoporous Silicon Dioxide for the Delivery of Large and Small Molecules

Drug Development
Dec, 2025
A “Function-First” Antibody Discovery Platform for Best-in-Class Therapeutics

A “Function-First” Antibody Discovery Platform for Best-in-Class Therapeutics

Drug Discovery
Dec, 2025
Integrated Solutions to Accelerate Drug Discovery

Integrated Solutions to Accelerate Drug Discovery

Drug Discovery
Nov, 2025
Automation Then And Now – A Strategic Perspective On The Evolution Of Lab Automation Over Two Decades

Automation Then And Now – A Strategic Perspective On The Evolution Of Lab Automation Over Two Decades

Drug Discovery
Nov, 2025

Latest News

See all
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Drug Discovery
Jan, 2026
Top 25 of ’25: Discovery & Development eBook

Top 25 of ’25: Discovery & Development eBook

Jan, 2026
AI and Simulations Reveal a Single Weak Spot in Herpes Virus Fusion

AI and Simulations Reveal a Single Weak Spot in Herpes Virus Fusion

Drug Discovery
Dec, 2025

Thought Leadership
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Vice President, Head of Chemistry, Rapafusyn Pharmaceuticals
Zoran Rankovic Director, Centre for Chemical Biology & Therapeutics, St. Jude Children’s Research Hospital
Kyle Eastman VP and Head of Chemistry, Halda Therpeutics
Danette Daniels Vice President of the Protein Degrader Platform, Foghorn Therapeutics
Drug Discovery
Jan, 2026
Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Stefan Schiesser Director Of Medicinal Chemistry, AstraZeneca
Drug Discovery
Nov, 2025
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Aline Miller Professor of Biomolecular Engineering, University of Manchester
Vasiliki Kalodimou Professor, European University-Cyprus – Frankfurt Branch
Maryna Panamarova 3D Cellular Modelling Specialist, Cellular Operations, Wellcome Sanger Institute
Andy Wiranata Wijaya BioProcess Development Lead, Nestlé
Drug Discovery
Oct, 2025
Advancing Drug Discovery Ebook Ad

Market Insight: Across R&D Stages

Better Antibodies for Parkinson’s Disease

Therapeutics
Sep, 2025

Insights into Patient Resilience from Antibody Discovery

Therapeutics
Sep, 2025

Targeting TREM2 with Bicyclic Peptides

Therapeutics
Sep, 2025

Understanding The Role Of Microglia In Alzheimer’s Disease

Therapeutics
Sep, 2025

From Genes to Brains: Linking Genetic Risk Factors to Neuronal Dysfunctions in Alzheimer’s Disease

Therapeutics
Sep, 2025

Donor to Donor Variability in Pharmacology: Mole Hill Or Mountain?

Drug Discovery
Nov, 2025

Unfolding Precision Medicines Using Phenotypic Screening In Primary Human Cells

Drug Discovery
Nov, 2025

AI-Powered Human Brain Organoid Platform To Transform CNS Drug Discovery

Drug Discovery
Nov, 2025

LNPs for Cell Type-Specific Gene Targeting in Patient Liver-Derived Fibrosis Organoids

Drug Discovery
Nov, 2025

WEE1 Degrader: A New Hope for Solid Tumours

Drug Discovery
Nov, 2025

Formulating Proteins For Maximum Stability

Drug Development
Dec, 2025

FAST Protein-Enabled Proteolipid Vehicles: A Novel Platform For Advanced Gene Therapy Delivery

Drug Development
Dec, 2025

Peptide ZIP Code Targeting

Drug Development
Nov, 2025

Co-Delivery and Surface Engineering with Sphingomyelin Nanoparticles

Drug Development
Nov, 2025

Beyond Short-Acting Peptide With the FluidCrystal Depot

Drug Development
Nov, 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.